Search
for
Sort by
Research 301–330 of 595
- Immune therapies for alopecia areata: evidence and new perspectives
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- The Trilogy of Skin Regeneration via Metal-Organic Frameworks Nanomedicine: Precision Management of Refractory Wounds, Pathological Scarring, and Hair Follicle Reactivation
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- 185 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- 004 Cell-based therapy may be effective in alopecia areata: Preclinical evidence that autologous, peripheral regulatory γdT cells are preventive in human ex vivo and therapeutic in human in vivo models
- JAK Inhibitors for Treatment of Alopecia Areata
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease Pathways
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Comparative spatial transcriptomics of hair follicle-T cell interactions in mouse, dog and human reveals conserved drivers of primary cicatricial alopecia
- Genome-wide association study of atopic and autoimmune comorbidities in alopecia areata
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- 937 Disruption of the innate lymphoid cell network alters the hair cycle during induced anagen
- Author response: IL18 signaling promotes homing of mature Tregs into the thymus
- Decision letter: IL18 signaling promotes homing of mature Tregs into the thymus
- Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases